Stock Report

Fredun Pharmaceuticals posts net profit of Rs. 1.87 crore in Q3FY22

Posted On : 2022-01-28 19:53:01( TIMEZONE : IST )

Fredun Pharmaceuticals Ltd has reported Standalone financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 54.2325 crores during the period ended December 31, 2021 as compared to Rs. 54.7624 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 1.8716 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 1.8397 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 4.22 for the period ended December 31, 2021 as compared to Rs. 4.61 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 54.2325 crs	₹54.7624 crs	-0.97%
Net Profit	₹1.8716 crs	₹1.8397 crs	1.73%
EPS	₹4.22	₹4.61	-8.46%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 54.2325 crores during the period ended December 31, 2021 as compared to Rs.45.5678 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.1.8716 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.1.3366 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.4.22 for the period ended December 31, 2021 as compared to Rs.3.35 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 54.2325 crs	₹45.5678 crs	19.01%
Net Profit	₹1.8716 crs	₹1.3366 crs	40.03%
EPS	₹4.22	₹3.35	25.97%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.154.2443 crores during the 9 Months period ended December 31, 2021 as compared to Rs.92.9102 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.4.0396 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.2.1993 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.10.13 for the 9 Months period ended December 31, 2021 as compared to Rs.5.51 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹154.2443 crs	₹92.9102 crs	66.01%
Net Profit	₹4.0396 crs	₹2.1993 crs	83.68%
EPS	₹10.13	₹5.51	83.85%

Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 1091.50 as compared to the previous close of Rs. 1064.45. The total number of shares traded during the day was 4906 in over 207 trades.

The stock hit an intraday high of Rs. 1114.50 and intraday low of 1011.25. The net turnover during the day was Rs. 5268303.00.